FDA Inspection 988951 — Nationwide Laboratories, LLC

Nationwide Laboratories, LLC — FEI 3012555723

The FDA completed an inspection of Nationwide Laboratories, LLC on Aug 19, 2016 in Iselin, NJ. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 7 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Aug 19, 2016
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Iselin, NJ (United States)

Citations

IDCFRDescription
187621 CFR 211.180(b)Record maintenance 1 year (except exempt OTC)
191421 CFR 211.166(a)Lack of written stability program
194321 CFR 211.180(e)(1)Review of representative number of batches
202821 CFR 211.192Extent of discrepancy, failure investigations
241921 CFR 211.198(a)Complaint Handling Procedure
435921 CFR 211.170(b)(1)Retention time of reserve samples, in general
900121 CFR 211.22(a)Lack of quality control unit

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.